Caries Prevention Potential of Pearl Powder Versus CPP-ACP on Enamel White Spot Lesions
NCT ID: NCT03973554
Last Updated: 2019-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
58 participants
INTERVENTIONAL
2019-10-30
2021-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remineralization Potential of Pearl Powder Compared to CPP-ACP on Enamel White Spot Lesions
NCT03976583
Efficacy of Different Agents in Treatment of Initial Caries on Smooth Surfaces in Permanent Teeth in Children
NCT05206539
Remineralization Effect of Eggshell Powder on Post-orthodontic White Spot Lesions Compared to CPP-ACP
NCT03963791
Effect of Casein Phosphopeptide Amorphous Calcium Phosphate Fluoride Varnish on Remineralization of White Spot Lesion in Primary Teeth
NCT03865680
Effect of CPP-ACP With/Without Fl on White Spot Lesion,Salivary pH and fl Release in High Caries Risk Patients
NCT03656432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pearl powder
natural product, support bone and joint health
pearl powder
natural product, support bone and joint health
CPP-ACP
product for professional use containing the active ingredient (CPP-ACP), a special milk-derived protein that has a unique ability to release bio-available calcium and phosphate to tooth surfaces.
CPP-ACP
Remineralising sugar free dental topical crème, containing bio-available calcium and phosphate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pearl powder
natural product, support bone and joint health
CPP-ACP
Remineralising sugar free dental topical crème, containing bio-available calcium and phosphate
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cooperative patient
* completion of orthodontic therapy
* presence of at least two white spot lesions on the labial surface of six maxillary anterior teeth, that were not present before orthodontic treatment
Exclusion Criteria
* lack of patients compliance
* allergy to milk products
* pregnant or lactating women
* presence of dentin caries, restorations, or enamel hypoplasia on maxillary anterior teeth
* presence of periodontal pockets around maxillary anterior teeth
12 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruba Alaa El Din Adel El Damarisy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ruba Alaa El Din Adel El Damarisy
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ruba A El Damarisy, MDS
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
omar shaalan, lecturer
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.